Where are we going with preimplantation genetic diagnosis?

Krahn, Timothy
May 2007
CMAJ: Canadian Medical Association Journal;5/8/2007, Vol. 176 Issue 10, p1445
Academic Journal
The article comments on the decision the British Human Fertilization and Embryology Authority to license preimplantation genetic diagnosis for hereditary breast and ovarian cancer and hereditary non-polyopsis colorectal cancer. The author believes that the agency's decision has downgraded its criteria for "significant risk" of being affected by a serious inherited genetic condition.


Related Articles

  • ESHRE PGD Consortium data collection IV: May–December 2001. K. Sermon; C. Moutou; J. Harper; J. Geraedts; P. Scriven; L. Wilton; M.C. Magli; A. Michiels; S. Viville; C. De Die // Human Reproduction;Jan2005, Vol. 20 Issue 1, p19 

    The ESHRE PGD Consortium was formed in 1997 to survey the practice of preimplantation genetic diagnosis (PGD). Since then, three reports have been published giving an overview on PGD from an ever-increasing number of centres and reporting on an increasing number of PGD cycles and pregnancies and...

  • Should IVF centers offer preimplantation genetic diagnosis? No. PGD's technical difficulty, learning curve, and costs warrant caution. Sable, David B. // Contemporary OB/GYN;Mar2003, Vol. 48 Issue 3, p54 

    Stresses that fertilization in vitro (IVF) centers should not offer preimplantation genetic diagnosis (PGD). Potential of PGD as a diagnostic test; Limitations of the technology; Technical concerns on PGD.

  • PGD gender selection for non-Mendelian disorders with unequal sex incidence. David J. Amor; Carolyn Cameron // Human Reproduction;Apr2008, Vol. 23 Issue 4, p729 

    Preimplantation genetic diagnosis (PGD) was originally developed for couples whose potential offspring were at risk of severe Mendelian disorders, but has since been extended to other indications. One possible use of PGD is to perform gender selection for couples whose offspring are at increased...

  • Preimplantation genetic diagnosis for familial dysautonomia. Rechitsky, Svetlana; Verlinsky, O; Kuliev, A; Ozen, RS; Masciangelo, C; Lifchez, A; Verlinsky, Y // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Jun2003, Vol. 6 Issue 4, p488 

    Presents a study that investigated preimplantation genetic diagnosis for familial dysautonomia, resulting in a triplet pregnancy and birth of three unaffected children. Information on familial dysautonomia; Materials and methods used in the study; Results; Discussion.

  • Current status of preimplantation diagnosis for single gene disorders. Verlinsky, Yury; Kuliev, Anver // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Sep2003, Vol. 7 Issue 2, p145 

    Preimplantation genetic diagnosis (PGD) has become an established procedure for avoiding the birth of affected children with single gene disorders. PGD is performed through polar body or blastomere biopsy, which has no deleterious effect on pre- and post-implantation development. This review...

  • Should IVF centers offer preimplantation genetic diagnosis? Yes. PGD can improve ART efficiency and practice standards. Kuliev, Anver; Verlinsky, Yury // Contemporary OB/GYN;Mar2003, Vol. 48 Issue 3, p54 

    Suggests that fertilization in vitro (IVF) centers should offer preimplantation genetic diagnosis (PGD). Advantages of using PGD; Overview of how PGD is used for chromosomal abnormalities; Clinical value in using PGD.

  • Preimplantation genetic diagnosis to prevent genetic disorders in children. Lashwood, Alison // British Journal of Nursing;1/27/2005, Vol. 14 Issue 2, p64 

    Preimplantation genetic diagnosis (PGD) is an alternative reproductive option for couples at risk of having a child affected with a genetic disorder. Although prenatal diagnosis (PND) has been available for many years, it is not acceptable to many owing to issues relating to termination of...

  • Extending preimplantation genetic diagnosis: medical and non-medical uses. Robertson, J. A. // Journal of Medical Ethics;Aug2003, Vol. 29 Issue 4, p213 

    New uses of preimplantation genetic diagnosis (PGD) to screen embryos prior to transfer raise ethical, legal, and policy issues that deserve close attention. Extensions for medical purposes, such as to identify susceptibility genes, late onset disease, and human leukocyte antigen (HLA) matching,...

  • Clinical application of multiple displacement amplification in preimplantation genetic diagnosis. Hellani, Ali; Coskun, Serdar; Tbakhi, Abdelghhani; Al-Hassan, Saad // Reproductive BioMedicine Online (Reproductive Healthcare Limited;Mar2005, Vol. 10 Issue 3, p376 

    Multiple displacement amplification (MDA) is a technique used in the amplification of very small amounts of DNA. MDA is reported to yield large quantities of high-quality DNA. The applicability of MDA to single cells was recently demonstrated as a potential technique for preimplantation genetic...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics